Lupus & antiphospholipid syndrome
16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends
Methodological detailsliterature review, Conclusions presented at a special session, 16th International Congress on aPL, Manchester, UK, September 2019
- Literature review
- Conclusions presented at a special session, 16th International Congress on aPL, Manchester, UK, September 2019
Scope
As issued by the authors
Antiphospholipid syndrome (APS) laboratory diagnostics: non-criteria aPL (aPS/PT, antibodies to domain 4/5 of β2GPI, antibodies to protein/HLA-DR complex); Lupus anticoagulant (LA) testing in the 'new' oral anticoagulants' era; value of triple positivity in aPL risk assessment
Original publication
16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends. Lupus. Published 7 November 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →